Abstract: A lighting device according to an embodiment of the present invention comprises: a heat dissipating frame having a receiving recess formed therein and a plurality of insertion holes formed in the upper surface thereof; a light source module mounted on an upper surface of the heat dissipating frame, and including a first substrate in which a plurality of coupling holes is formed at positions facing the plurality of insertion holes; and a control module received in the receiving recess of the heat dissipating frame, and including a second substrate having a plurality of connecting terminals formed on a side surface thereof and projecting in a lengthwise direction, wherein the control module is disposed vertically upright within the receiving recess such that the plurality of connecting terminals faces upward, and the plurality of connecting terminals is inserted in the plurality of insertion holes and the plurality of coupling holes is connected to the light source module.

Abstract: An energy storage apparatus includes a chamber including a receiving space therein, battery racks including first and second battery rack groups positioned in the receiving space and spaced apart from each other while facing each other with reference to a center of the receiving space, an upper duct positioned above the receiving space configured to supply cooling fluid to a cooling space which is a space between the first battery rack group and the second battery rack group, a cooling unit positioned outside the receiving space and configured to cool the cooling fluid, and a fluid moving member comprising a moving space where the cooling fluid heated after cooling the battery racks moves to the cooling unit, in which the cooling unit is supplied with the heated cooling fluid from the moving space, cools the supplied cooling fluid, and then supplies a resultant fluid to the upper duct.

Abstract: The present invention relates to a battery energy storage system including: a plurality of battery boxes provided with a plurality of battery packs; a plurality of power converter systems respectively connected to the plurality of battery boxes to selectively charge or discharge the plurality of battery boxes through alternating current supplied from an external power source device; a transformer disposed between the external power source device and the plurality of power converter systems; and a controller controlling the plurality of power converter systems to selectively charge or discharge the plurality of battery boxes.

Abstract: A dimming circuit includes an active dimmer configured to apply input power Vin to an amplification module or an error compensation module, the amplification module configured to amplify an output current of the active dimmer, and the error compensation module configured to correct an error or distortion of the amplification module. The amplification module and the error compensation module are connected in a feedback form.

Abstract: The present disclosure discloses an apparatus and method for maintaining a charge amount of a secondary battery. The present disclosure reduces a charge amount or increases a discharge amount when a larger charge amount than a required proper charge amount is charged in the secondary battery. Also, the present disclosure reduces a discharge amount or increases a charge amount when a smaller charge amount than a required proper charge amount is charged in the secondary battery. Through this, a proper charge amount may be maintained.

Abstract: The invention is directed to a formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b and R3-R7 are herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

Abstract: A lighting device according to an embodiment of the present invention comprises: a heat dissipating frame having a receiving recess formed therein and a plurality of insertion holes formed in the upper surface thereof; a light source module mounted on an upper surface of the heat dissipating frame, and including a first substrate in which a plurality of coupling holes is formed at positions facing the plurality of insertion holes; and a control module received in the receiving recess of the heat dissipating frame, and including a second substrate having a plurality of connecting terminals formed on a side surface thereof and projecting in a lengthwise direction, wherein the control module is disposed vertically upright within the receiving recess such that the plurality of connecting terminals faces upward, and the plurality of connecting terminals is inserted in the plurality of insertion holes and the plurality of coupling holes is connected to the light source module.

Abstract: A dimming circuit includes an active dimmer configured to apply input power Vin to an amplification module or an error compensation module, the amplification module configured to amplify an output current of the active dimmer, and the error compensation module configured to correct an error or distortion of the amplification module. The amplification module and the error compensation module are connected in a feedback form.

Abstract: The invention is directed to a formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b and R3-R7 are herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

Abstract: Disclosed are a wired-wireless combined power transmission apparatus and a method using the same. The wired-wireless combined power transmission apparatus includes a rectifying unit converting an AC input signal into a DC signal, a transformer unit transforming a size of the input signal, which has been converted into the DC signal, into a predetermined size, a wireless power transmission unit receiving the signal transformed by the transformer unit to wirelessly transmit power, and a wired power supply unit receiving the signal transformed by the transformer unit to supply power through a cable. The advantages and disadvantages of the wired power transmission apparatus and the wireless power transmission apparatus are supplemented to each other, so that the power conversion efficiency and the versatility are improved.

Abstract: The invention provides methods of detecting cancer and detecting activity of IDH inhibitors, and methods of screening for IDH inhibitors by detecting levels of H3K9me2.

Abstract: Provided are system and method for correcting a state-of-charging (SOC) of a battery. The system for correcting the SOC of the battery includes an SOC measuring unit measuring an SOC value of the battery, a storage unit storing preset operation ranges to determine whether charging/discharging of the battery is compensated, a determining unit determining an operation range corresponding to the SOC value of the battery among the preset operation ranges, and an SOC correcting unit adjusting a dead band in charging/discharging directions or charging/discharging power according to the result determined in the determining unit to correct the SOC value of the battery.

Abstract: The invention is directed to a formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b and R3-R7 are herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

Abstract: The invention is directed to novel pyrrolopyrimidine compounds of formula (1) wherein R1, R2y, R4, R8-R11, A and L are defined herein and to salts, including pharmaceutically acceptable salts thereof. The compounds of the present invention are CDK4/6 inhibitors and could be useful in the treatment of diseases and disorders mediated by CDK4/6, such as cancer, including mantle cell lymphoma, liposarcoma, non small cell lung cancer, melanoma, squamous cell esophageal cancer and breast cancer. The invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CDK4/6 activity and to the treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

Abstract: The invention is directed to a formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b and R3-R7 are described herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant I DH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

Abstract: The present disclosure discloses an apparatus and method for maintaining a charge amount of a secondary battery. The present disclosure reduces a charge amount or increases a discharge amount when a larger charge amount than a required proper charge amount is charged in the secondary battery. Also, the present disclosure reduces a discharge amount or increases a charge amount when a smaller charge amount than a required proper charge amount is charged in the secondary battery. Through this, a proper charge amount may be maintained.

Abstract: The present invention discloses an apparatus and method for varying a usable band range of a battery. The apparatus for varying a usable band range of a battery according to the present invention comprises a sensor for measuring and outputting an electrical characteristic value of the battery; and a controller for calculating the amount of charged or discharged energy of the battery from the electrical characteristic value and varying a usable band range of the battery that is charged and discharged, to maintain the pre-established amount of usable energy depending on the degradation degree of the battery. In accordance with the present invention, a usable band range of a battery can be established depending on the degradation degree of the battery, thereby improving the life time thereof.

Abstract: A battery pack and a power generation circuit in the battery pack are disclosed. The battery pack includes a battery cell unit including battery cells connected in series, a charge/discharge switch connected between the battery cell unit and charge/discharge terminals, a charge/discharge controller controlling the charge/discharge switch to charge or discharge the battery cell unit, and a voltage converter electrically connected in parallel to the charge/discharge switch and dropping a voltage of the battery cell unit, and outputting the dropped voltage as power of the charge/discharge controller.

Abstract: The invention is directed to a formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b and R3-R7 are herein. The invention is also directed to compositions containing a compound of formula (I) and to the use of such compounds in the inhibition of mutant IDH proteins having a neomorphic activity. The invention is further directed to the use of a compound of formula (I) in the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer.

Abstract: Disclosed is an apparatus and method for controlling charge and discharge of a secondary battery. The apparatus for controlling charge and discharge of the secondary battery includes the power control unit calculates an amount of discharging power of the secondary battery, and when voltage value of the secondary battery is less than a preset reference voltage value, outputs a compensation charge control signal to charge the secondary battery with an amount of charging power obtained by adding an amount of power compensation to the calculated amount of discharging power. According to the present disclosure, the problem of a charge amount of the secondary battery reducing gradually with increasing charge and discharge cycles of the secondary battery may be prevented by compensating for the charge amount of the secondary battery.